| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.51M | - | |
| Other | 52.8K | $8.46M | - | |
| Other | 46.8K | $7.49M | - | |
| Other | 39.6K | $6.35M | -36,937 | |
| Other | 36.8K | $5.91M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | Rastetter William H48 | Director | Sale+OE | 18,000 | $151.82 | $2,732,689.80 | -30.8% | -9.6% | - | |
| Nov 4, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 300 | $141.97 | $42,591.00 | -0.2% | -3.9% | - | |
| Aug 7, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 106,322 | $126.41 | $13,440,280.97 | -17.1% | +22.4% | - | |
| Jul 10, 2025 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 457 | $135.00 | $61,695.00 | -8.8% | +3.1% | - | |
| Jul 9, 2025 | Onyia Jude54 | Chief Scientific Officer | Sale+OE | 59,819 | $130.46 | $7,803,687.65 | -76.6% | +2.6% | - | |
| Jul 2, 2025 | Onyia Jude54 | Chief Scientific Officer | Sale+OE | 20,362 | $130.13 | $2,649,737.60 | -52.7% | +8.5% | - | |
| May 27, 2025 | Gorman Kevin Charles55 | Director | Sell | 9,613 | $120.38 | $1,157,211.02 | -1.8% | +9.3% | +27.1% | |
| May 5, 2025 | Rastetter William H48 | Director | Sale+OE | 30,000 | $110.20 | $3,305,952.00 | -44.5% | +16.7% | +23.1% | |
| Feb 14, 2025 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 2,218 | $116.44 | $258,263.73 | -2.1% | +4.6% | +7.9% | |
| Feb 13, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 5,844 | $116.69 | $681,914.46 | -0.6% | +1.6% | +6.2% |